Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylergonovine plus oxytocin vs carbetocin for prevention of postpartum hemorrhage in cesarean section
TCTR20200401001Phase 4Enrolling by invitation
- Start
- Mar 2020
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylergometrine, oxytocin, carbetocin in postpartum hemorrhage (PPH), sponsored by None. Started Mar 2020; status: enrolling by invitation.
02
Drugs
methylergometrineoxytocincarbetocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on TCTR20200401001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200401001.